Literature DB >> 23946118

Telomere phenotypes in females with heterozygous mutations in the dyskeratosis congenita 1 (DKC1) gene.

Jonathan K Alder1, Erin M Parry, Srinivasan Yegnasubramanian, Christa L Wagner, Lawrence M Lieblich, Robert Auerbach, Arleen D Auerbach, Sarah J Wheelan, Mary Armanios.   

Abstract

Dyskeratosis congenita (DC) is a telomere-mediated syndrome defined by mucocutaneous features. The X-linked mode of inheritance accounts for half the cases, and is thought to predominantly manifest in childhood as bone marrow failure. We identified two male probands who presented in the fifth decade with idiopathic pulmonary fibrosis and cancer. Their pedigrees displayed consecutively affected generations. Five of six females (83%) manifested mucocutaneous features of DC, and two had wound-healing complications. No mutations in autosomal dominant telomere genes were present, but exome sequencing revealed novel variants in the X-chromosome DKC1 gene that predicted missense mutations in conserved residues, p.Thr49Ser and p.Pro409Arg. Variants segregated with the telomere phenotype, and affected females were heterozygotes, showing skewed X-inactivation. Telomerase RNA levels were compromised in cells from DKC1 mutation carriers, consistent with their pathogenic role. These findings indicate that females with heterozygous DKC1 mutations may be at increased risk for developing penetrant telomere phenotypes that, at times, may be associated with clinical morbidity.
© 2013 WILEY PERIODICALS, INC.

Entities:  

Keywords:  DKC1; Dyskeratosis congenita; myelodysplastic syndrome; pulmonary fibrosis; telomerase

Mesh:

Substances:

Year:  2013        PMID: 23946118      PMCID: PMC3926107          DOI: 10.1002/humu.22397

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  30 in total

1.  A telomerase component is defective in the human disease dyskeratosis congenita.

Authors:  J R Mitchell; E Wood; K Collins
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

Review 2.  Dyskeratosis congenita in all its forms.

Authors:  I Dokal
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

3.  The gastrointestinal manifestations of telomere-mediated disease.

Authors:  Naudia L Jonassaint; Nini Guo; Joseph A Califano; Elizabeth A Montgomery; Mary Armanios
Journal:  Aging Cell       Date:  2013-01-04       Impact factor: 9.304

4.  Subclinical lung disease, macrocytosis, and premature graying in kindreds with telomerase (TERT) mutations.

Authors:  Alberto Diaz de Leon; Jennifer T Cronkhite; Cuneyt Yilmaz; Cecelia Brewington; Richard Wang; Chao Xing; Connie C W Hsia; Christine Kim Garcia
Journal:  Chest       Date:  2011-02-24       Impact factor: 9.410

5.  Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1.

Authors:  S W Knight; N S Heiss; T J Vulliamy; C M Aalfs; C McMahon; P Richmond; A Jones; R C Hennekam; A Poustka; P J Mason; I Dokal
Journal:  Br J Haematol       Date:  1999-11       Impact factor: 6.998

6.  Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita.

Authors:  Bari J Ballew; Meredith Yeager; Kevin Jacobs; Neelam Giri; Joseph Boland; Laurie Burdett; Blanche P Alter; Sharon A Savage
Journal:  Hum Genet       Date:  2013-01-18       Impact factor: 4.132

7.  Human RTEL1 deficiency causes Hoyeraal-Hreidarsson syndrome with short telomeres and genome instability.

Authors:  Tangui Le Guen; Laurent Jullien; Fabien Touzot; Michael Schertzer; Laetitia Gaillard; Mylène Perderiset; Wassila Carpentier; Patrick Nitschke; Capucine Picard; Gérard Couillault; Jean Soulier; Alain Fischer; Isabelle Callebaut; Nada Jabado; Arturo Londono-Vallejo; Jean-Pierre de Villartay; Patrick Revy
Journal:  Hum Mol Genet       Date:  2013-04-15       Impact factor: 6.150

Review 8.  The telomere syndromes.

Authors:  Mary Armanios; Elizabeth H Blackburn
Journal:  Nat Rev Genet       Date:  2012-09-11       Impact factor: 53.242

9.  Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita.

Authors:  Erin M Parry; Jonathan K Alder; Stella S Lee; John A Phillips; James E Loyd; Priya Duggal; Mary Armanios
Journal:  J Med Genet       Date:  2011-03-17       Impact factor: 6.318

10.  Constitutional mutations in RTEL1 cause severe dyskeratosis congenita.

Authors:  Amanda J Walne; Tom Vulliamy; Michael Kirwan; Vincent Plagnol; Inderjeet Dokal
Journal:  Am J Hum Genet       Date:  2013-02-28       Impact factor: 11.025

View more
  48 in total

Review 1.  The molecular genetics of the telomere biology disorders.

Authors:  Alison A Bertuch
Journal:  RNA Biol       Date:  2015-09-23       Impact factor: 4.652

Review 2.  Cellular Senescence: The Trojan Horse in Chronic Lung Diseases.

Authors:  Shruthi Hamsanathan; Jonathan K Alder; Jacobo Sellares; Mauricio Rojas; Aditi U Gurkar; Ana L Mora
Journal:  Am J Respir Cell Mol Biol       Date:  2019-07       Impact factor: 6.914

3.  Synonymous Mutation in DKC1 Causes Telomerase RNA Insufficiency Manifesting as Familial Pulmonary Fibrosis.

Authors:  Valeriya Gaysinskaya; Susan E Stanley; Soheir Adam; Mary Armanios
Journal:  Chest       Date:  2020-07-22       Impact factor: 9.410

4.  The genetic basis of idiopathic pulmonary fibrosis.

Authors:  Jonathan A Kropski; Timothy S Blackwell; James E Loyd
Journal:  Eur Respir J       Date:  2015-04-02       Impact factor: 16.671

5.  Hepatopulmonary syndrome is a frequent cause of dyspnea in the short telomere disorders.

Authors:  Amany I Gorgy; Naudia L Jonassaint; Susan E Stanley; Ayman Koteish; Amy E DeZern; Jolan E Walter; Sabrina C Sopha; James P Hamilton; Julie Hoover-Fong; Allen R Chen; Robert A Anders; Ihab R Kamel; Mary Armanios
Journal:  Chest       Date:  2015-10       Impact factor: 9.410

6.  Cancer spectrum and outcomes in the Mendelian short telomere syndromes.

Authors:  Kristen E Schratz; Lisa Haley; Sonye K Danoff; Amanda L Blackford; Amy E DeZern; Christopher D Gocke; Amy S Duffield; Mary Armanios
Journal:  Blood       Date:  2020-05-28       Impact factor: 22.113

7.  What the genetics "RTEL"ing us about telomeres and pulmonary fibrosis.

Authors:  Susan E Stanley; Imre Noth; Mary Armanios
Journal:  Am J Respir Crit Care Med       Date:  2015-03-15       Impact factor: 21.405

8.  Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis.

Authors:  Jonathan A Kropski; Lisa R Young; Joy D Cogan; Daphne B Mitchell; Lisa H Lancaster; John A Worrell; Cheryl Markin; Na Liu; Wendi R Mason; Tasha E Fingerlin; David A Schwartz; William E Lawson; Timothy S Blackwell; John A Phillips; James E Loyd
Journal:  Am J Respir Crit Care Med       Date:  2017-06-01       Impact factor: 21.405

9.  Telomerase mutations in smokers with severe emphysema.

Authors:  Susan E Stanley; Julian J L Chen; Joshua D Podlevsky; Jonathan K Alder; Nadia N Hansel; Rasika A Mathias; Xiaodong Qi; Nicholas M Rafaels; Robert A Wise; Edwin K Silverman; Kathleen C Barnes; Mary Armanios
Journal:  J Clin Invest       Date:  2014-12-22       Impact factor: 14.808

10.  Investigation of chromosome X inactivation and clinical phenotypes in female carriers of DKC1 mutations.

Authors:  Jialin Xu; Payal P Khincha; Neelam Giri; Blanche P Alter; Sharon A Savage; Judy M Y Wong
Journal:  Am J Hematol       Date:  2016-11-04       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.